XTX Topco’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-71,040
| Closed | -$682K | – | 3285 |
|
2024
Q4 | $682K | Sell |
71,040
-111,848
| -61% | -$1.07M | 0.06% | 513 |
|
2024
Q3 | $523K | Buy |
182,888
+58,587
| +47% | +$168K | 0.04% | 784 |
|
2024
Q2 | $363K | Buy |
124,301
+33,651
| +37% | +$98.3K | 0.03% | 841 |
|
2024
Q1 | $289K | Buy |
90,650
+75,984
| +518% | +$242K | 0.04% | 887 |
|
2023
Q4 | $49.3K | Sell |
14,666
-26,116
| -64% | -$87.8K | 0.01% | 1235 |
|
2023
Q3 | $97.1K | Sell |
40,782
-192,711
| -83% | -$459K | 0.02% | 1190 |
|
2023
Q2 | $411K | Buy |
233,493
+82,404
| +55% | +$145K | 0.07% | 503 |
|
2023
Q1 | $465K | Buy |
151,089
+27,053
| +22% | +$83.3K | 0.1% | 337 |
|
2022
Q4 | $657K | Buy |
124,036
+107,856
| +667% | +$572K | 0.14% | 194 |
|
2022
Q3 | $57K | Buy |
+16,180
| New | +$57K | 0.01% | 1011 |
|